News

GlaxoSmithKline to publish clinical trials after US lawsuit

BMJ 2004; 328 doi: 10.1136/bmj.328.7455.1513-a (Published 24 June 2004)
Cite this as: BMJ 2004;328:1513.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Liza Gibson
  1. London

    The world's second largest pharmaceutical company, GlaxoSmithKline, is to publish summaries of the results of all its clinical trials on its website once a product has been launched.

    GlaxoSmithKline said it has been considering the move for several months now, but it follows on the heels of a US lawsuit, filed by Eliot Spitzer, New York state's attorney general, earlier this month.

    Mr Spitzer alleged the company engaged in “repeated and persistent fraud” for concealing the results of clinical studies for its antidepressant paroxetine; these suggested the drug was ineffective and unsafe in treating depression in children and adolescents (12 June, p 1395).

    Mr Spitzer also had an internal …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular